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Background: The aim of this study was to analyze the influence of active and passive smoking on cardiorespiratory
responses in asymptomatic adults during a sub-maximal-exertion incremental test.
Methods: The participants (n = 43) were divided into three different groups: active smokers (n = 14; aged 36.5 ± 8
years), passive smokers (n = 14; aged 34.6 ± 11.9 years) and non-smokers (n = 15; aged 30 ± 8.1 years). They all
answered the Test for Nicotine Dependence and underwent anthropometric evaluation, spirometry and
ergospirometry according to the Bruce Treadmill Protocol.
Results: VO2max differed statistically between active and non-smokers groups (p < 0.001) and between non-smokers
and passive group (p=0.022). However, there was no difference between the passive and active smokers groups
(p=0.053). Negative and significant correlations occurred between VO2max and age (r = − 0.401, p = 0.044), percentage
of body fat (r = − 0.429, p = 0.011), and waist circumference (WC) (r = − 0.382, p = 0.025).
Conclusion: VO2max was significantly higher in non-smokers compared to active smokers and passive smokers.
However, the VO2max of passive smokers did not differ from active smokers.
Keywords: Cardiovascular diseases, Exercise test, Oxygen consumption, SmokingBackground
Cardiorespiratory impairment increases morbidity and is
an independent predictor of all-cause mortality [1]. Indi-
viduals with low cardiorespiratory capacity are more likely
to develop systemic arterial hypertension (SAH) [2], dia-
betes [3], and metabolic syndrome [4] and have high mor-
tality rates due to cardiovascular disease [5] and cancer
(CA) [6] than individuals with high cardiorespiratory
capacity. One way to evaluate cardiorespiratory ability
is through the cardiopulmonary exercise test (CPET) or
ergospirometry. Its effectiveness lies in its reflection of the
strength of the cardiorespiratory system and its changes
during exercise. One of the parameters used to estimate
cardiopulmonary functional capacity is the maximum con-
sumption of oxygen (VO2max) [7,8]. VO2max reflects the
maximum capacity of absorption, transportation and con-
sumption of oxygen (O2). VO2max is the most influential* Correspondence: dulciane@unisc.br
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unless otherwise stated.parameter of a person’s physical conditioning and is an in-
dependent and objective measure for the prognosis of car-
diovascular disease [8,9].
Smoking affects the response to the CPET [10,11].
Smokers have lower aerobic capacity and, thus, less oxy-
gen supply while they are exercising. Smoking also re-
quires an additional energetic cost, which is caused by
greater respiratory muscle work. Quitting smoking and
practicing physical activities regularly can make aerobic
function return to normal values [12]. The effects of pas-
sive smoking on cardiorespiratory capacity, however, are
rarely addressed. A recent randomized clinical trial iden-
tified cardiorespiratory and immunological changes in
healthy non-smoking individuals; these changes appeared
immediately after they were exposed to cigarette smoke
[13]. In 2008, Ren et al. [14] performed one of the first
studies to evaluate the hemodynamics and cardiopulmo-
nary function of flight attendants who were exposed to
cigarette smoke for over five years. These authors noted a
connection between passive smoking and SAH, but they
did not show significant cardiopulmonary impairment.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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influences that active and passive smoking have on cardio-
respiratory responses in asymptomatic adults throughout
a sub-maximal-exertion incremental test on a treadmill.
Methods
This transversal study was composed of smokers, non-
smokers and passive smokers, aged between 18 and 50
years and of both genders. In this study, among partici-
pants active smokers were considered those who had
smoked at least five cigarettes/day for 10 years prior to the
study (active smoker group); whereas passive smokers
were those who lived with at least one smoker or inter-
acted with a smoker at work for at least three years prior
to the study (passive smoker group); and the non-smokers
were those who had never smoked (non-smoker group).
Individuals who had cardiorespiratory disease, trauma-
orthopedic dysfunction, diabetes or CA were excluded
from the study, as were ex-smokers and individuals who
had been exposed to toxic inhalants.
The study enrolled 43 adults from the target popula-
tion. To calculate the sample size, we evaluated a differ-
ence in the average cardiorespiratory function in six
subjects, considering a standard deviation of 5%, a statis-
tical power of 90% and confidence interval of 95% [15].
This study was approved by the Research Ethics Com-
mittee of the University of Santa Cruz do Sul, and free
informed consent was obtained under protocol number
2682/2010 from every participant.
Initially, the level of nicotine dependence was evalu-
ated using the Fagerström Test for Nicotine Dependence
(FTND) [16-19]. The number of years the individuals
smoked and, in case of passive smoking, the period they
were exposed to cigarette smoke (minutes/day and the
number of years) were also recorded [20,21]. All exams
were performed by qualified professionals.
Anthropometric evaluation
The anthropometric evaluation was performed by measur-
ing body mass (kg) and height (cm) using an anthropomet-
ric scale. Body mass index (BMI) was calculated following
the criteria established by the World Health Organization
[22]. Using a non-elastic measuring tape, waist circumfer-
ence (WC) was measured bilaterally at the midpoint
between the iliac crest and the lower costal margin, ac-
cording to the criteria proposed by Heyward [23], and was
classified according to the 1st Brazilian Guideline for
Metabolic Syndrome Diagnosis and Treatment [24].
To determine the body fat percentage (%F), seven skin
folds were measured. These measures were different for
men and women, according to Jackson and Pollock’s proto-
col [25,26], and were performed with the LangeW Caliper
(Multimed, Skinfold Caliper, Gays Mills, WI, USA). Mea-
sures were taken three times in a rotational sequence toobtain an average for each individual at each location.
Jackson and Pollock’s approach [25] was used to calculate
body density (BD), and the Siri equation was used to ob-
tain %F.
Lung function evaluation
Lung function was evaluated using a portable spirometer
(EasyOneW, Model 2001 Diagnostic Spirometer, NDD
Medical Technologies, Andover, MA, USA) following
the protocol of the American Thoracic Society [27]. The
following variables were evaluated: forced vital capacity
(FVC), forced expiratory volume (VEF1), VEF1/FVC ratio
and peak expiratory flow (PEF). The curves for these pa-
rameters were compared to reference values for this
population [28].
Cardiorespiratory capacity
Treadmill cardiopulmonary exercise testing was performed
using the Bruce protocol [9] and was used to identify and
classify cardiorespiratory capacity (EcafixW EG treadmill-
700X, São Paulo, SP, Brazil). An aneroid sphygmoman-
ometer was used to measure systolic arterial pressure
(SAP) and diastolic arterial pressure (DAP) every 3 mi-
nutes throughout the test [29] and respiratory gas analysis
was recorded continuously throughout the test. Simultan-
eous, respiratory gas analysis was performed using breath
by breath analysis of O2 and CO2 on a TEEM 100 Meta-
bolic Analysis SystemW instrument (Aero Sport, Ann
Arbor, MI, USA), as previously validated by Novitsky [30].
All exams were performed in the morning at a controlled
room temperature. The oxygen and carbon dioxide sensors
were calibrated before each exercise test [31]. The VO2max
was defined as the maximum O2 consumption reached
during the last minutes of exercise during the exertion
test. VO2max was estimated, and the participants were
classified according to their functional capacity, following
criteria established by Pollock and Wilmore [32]. VO2max
was normalized to age, height and gender using the
formula published by Jones et al. [33]. The highest HR
reached during the exercises was defined as HR reached
(HRreached). The highest RQ was termed RQ peak
(RQpeak). The test was interrupted if the subject in-
dicated any discomfort that could prevent him/her from
continuing the test or when the individual reached 85% of
the maximum HR set by the Karvonen formula (220–age).
All individuals were informed and educated about the
procedure of the test.
Level of physical activity
To quantify their physical activity, all volunteers answered
the International Physical Activity Questionnaire (IPAQ–
short version). The short version of the IPAQ addresses
the number of days and minutes spent practicing phys-
ical activities as recreational and occupational activities,






(n = 15) (n = 14) (n = 14)
Male gender, n (%) 6 (40) 4 (28.5) 4 (28.5) 0.97
Age (years old) 30,4 ± 8.2 33.1 ± 11.8 37.2 ± 7.7 0.16
BMI (kg/m2) 23.6 ± 4.6 24.3 ± 4.2 27.2 ± 3.9 0.06
WC (cm) 74.1 ± 12.1† 77.2 ± 10.7 84.1 ± 8.5† 0.04
%F 20.9 ± 8.4 23.1 ± 6.6 24.1 ± 6.2 0.51
SAP resting (mmHg) 117.9 ± 10.4 120.3 ± 12.6 120.9 ± 9.3 0.73
DAP resting (mmHg) 76.1 ± 9.4 74.6 ± 7.4 74.6 ± 9.1 0.88
FVC (% pred) 95.8 ± 21.1 105 ± 15.8 104.2 ± 13.2 0.28
FEV1 (% pred) 89.4 ± 19.5* 102.8 ± 15.4 103 ± 10.8* 0.03
FEV1/FVC (% pred) 92.6 ± 9.2 97.4 ± 6.5 97.1 ± 5.4 0.15
BMI, body mass index; DAP, diastolic arterial pressure; FEV1, forced expiratory
volume in the first second; FEV1/FVC, ratio between FEV1 and FVC; FVC, forced
vital capacity; %F, percentage of body fat; SAP, systolic arterial pressure; WC,
waist circumference. Values are expressed as the mean ± SD. †Significant
difference between non-smokers and active smokers (p = 0.04). *Significant
difference between non-smokers and active smokers (p = 0.03). Significance was
accepted at p < 0.05.
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tained by summing the number of days and minutes or
hours of physical activities performed during the week
prior to the completion of the questionnaire. The levels of
physical activity were classified as sedentary, insufficiently
active, active, and intensely active by taking into con-
sideration the frequency, intensity, and length of these
activities [34].
In addition to the IPAQ and the Test for Nicotine
Dependence, the participants were asked to provide per-
sonal details such as age, gender, race and educational
background.
Statistical analysis
The statistical software SPSS (version 18.0, SPSS Inc.,
Chicago, Illinois, USA) was used for statistical analysis.
The Shapiro-Wilk test was used to determine the nor-
mality of the data distributions. Descriptive statistics
(mean, standard deviation and absolute frequency) were
calculated for most parameters. Fisher’s exact test was
used to compare the categorical variables among groups.
One-way analysis of variance (ANOVA) was used to
compare mean VO2max, followed by Tukey’s post-hoc
test and student’s T-test when necessary. Pearson’s cor-
relation test and Analysis of Covariance (ANCOVA) was
also performed to compare VO2max and its covariates
age, %F, WC and level of physical activity, among groups.
P < 0.05 was considered significant.
Results and discussion
The sample was composed of 43 Caucasian individuals
with an average age of 33.5 ± 9.6 years. The individuals
were allocated evenly into the active smoker group (n = 14;
aged 37.2 ± 7.7 years), passive smoker group (n = 14; aged
33.1 ± 11.8 years) and non-smoker group (n = 15; aged
30.4 ± 8.2 years). Table 1 shows their demographic, an-
thropometric and basic cardiopulmonary characteristics.
Most individuals from the sample (83.3%) had WC within
the normal range, but the non-smoker group and the active
smoker group had significantly different WC (p = 0.04).
The %F was classified as excellent, good, above average or
average in 37 individuals (72.9%). The spirometric analysis
revealed values within the normal range in all individuals.
According to the FTND, nine out of the 16 active smokers
had a medium/high/extremely high degree of nicotine
addiction. Instead, in seven individuals, the addiction de-
gree was low/awfully low. All active smokers had been
smoking for over 10 years. The average number of ciga-
rettes smoked was 20.6 ± 9.6 cigarette/day002E.
Among the passive smokers, most individuals were ex-
posed to cigarette smoke for over an hour per day (62.5%).
All of them had experienced this exposure for over three
years. Damage caused by smoking affects not only active
smokers but also non-smokers who are exposed tocigarette smoke at home, at work, in leisure environments,
at school and in other enclosed public areas [35]. Passive
smoking has been considered a significant risk factor for
the development and evolution of cardiopulmonary dys-
functions, including loss of endothelial function and cor-
onary artery disease [36,37].
There is a connection between passive smoking and
loss of lung function [38,21,39-41]. However, there is little
information about the impact of passive smoking on car-
diorespiratory capacity. Furthermore, studies that have
quantified the exposure to cigarette smoke have used dif-
ferent methods; these differences hamper and complicate
the interpretation of the data.
Flouris et al. [13] evaluated cardiorespiratory and im-
munological responses during physical activity training
after cigarette smoke exposure. Seventeen individuals of
both genders were exposed to cigarette smoke in a con-
trolled environment with a concentration of carbon mon-
oxide similar to what is found in restaurants and bars.
These individuals were monitored during and after the
completion of moderate physical activities. The authors
found cardiorespiratory (increased RQ) and immunological
(increased interleukins) changes immediately after expos-
ure to cigarette smoke.
In contrast, some studies have been inconsistent when
showing significant cardiopulmonary effects caused by
exposure to cigarette smoke. One of the first studies to
evaluate cardiopulmonary hemodynamics and cardiopul-
monary capacity related to residual effects of passive
smoking, Ren et al. [14] studied 79 flight attendants ex-
posed to cigarette smoke inside aircraft cabins for over
five years reported that passive smoking was linked to
Table 2 Variables obtained during the cardiopulmonary exercise test
Characteristics Non-smokers Passive smokers Active smokers p
(n = 15) (n = 14) (n = 14)
VO2max (% pred)* 118.44 ± 38.11
†** 89.75 ± 7.4† 75.13 ± 17.78** <0.001
RQ peak (l·min−1) 1.13 ± 0.3 1.2 ± 0.4 1.1 ± 0.3 0.82
HR resting (bpm) 70.6 ± 14.9 73.6 ± 11.8 77.6 ± 13.8 0.38
HR reached (bpm) 159.1 ± 19.6 160.1 ± 13.6 152.7 ± 13.9 0.42
SAP resting (mmHg) 117.9 ± 10.4 120.3 ± 12.6 120.9 ± 9.3 0.73
SAP reached (mmHg) 151.3 ± 11.2 148.9 ± 18.4 147.1 ± 9.1 0.70
DAD resting (mmHg) 76 ± 9.4 74.6 ± 7.4 74.6 ± 9.1 0.88
DAP reached (mmHg) 84.3 ± 5.6 85.3 ± 6.3 84.6 ± 7.4 0.91
DAP, diastolic blood pressure; HR; heart rate; RQ, respiratory quotient; SAP, systolic arterial pressure; VO2max, maximum oxygen consumption;. Values are expressed
as mean ± SD. p, p-value obtained through analysis of variance (ANOVA). *Analysis of covariance (ANCOVA) was also performed to compare VO2max and its
covariates age, %F, WC and level of physical activity, among groups. Significance was accepted at p < 0.05. †Significant difference between non-smokers and
passive smokers (p = 0.022). **Significant difference between non-smokers and active smokers (p < 0.001).
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temic consequences. However, in our study, there was evi-
dence of significant differences in CPET results between
passive smokers and non-smokers, as well as between
non-smokers and active smokers groups.
Table 2 shows the values obtained during the CPET in
each group. When evaluating VO2max in active, passive and
non-smoking individuals using CPET, significant differ-
ences were observed between groups (p < 0.001) (Figure 1).
When comparing VO2max between groups, after adjust-
ment for age, %F, WC and level of physical activity showed
a significant difference between the non-smoker and
passive smoker group (p = 0.022) even as non-smoker
and active group (p < 0.001). The passive and active
smoker groups showed a not significantly VO2maxdiffer-
ence (p = 0.053).
Several studies have reported a correlation between
VO2max and smoking. Kobayashi et al. [15] evaluated the
impact of smoking on cardiorespiratory responses duringFigure 1 Comparison of VO2max among groups after adjustment for bsub-maximal exercise activities. In their study, 18 healthy
men were evaluated (nine smokers: average of 15 ciga-
rettes/day for over five years; nine non-smokers). They
found that smoke harmed cardiorespiratory function while
exercising due to a reduction of the body capacity to
carry O2. Laukkanen et al. [6] evaluated determinants
of cardiorespiratory capacity in men aged 42 to 60 years
and found an inverse correlation between smoking and
VO2max [42]. Louie [43] conducted a running test in 27
teenagers smokers or non-smokers and showed that, even
in young individuals, smoking was associated with a sig-
nificant reduction of cardiopulmonary activity and exer-
cise tolerance; this effect remained even at light smoking
levels.
According to Kobayashi et al. [15], smoking signifi-
cantly worsens cardiorespiratory function during moder-
ate to severe exercises. This impairment happens because
the body’s capacity to carry O2 is reduced, resulting in
a higher anaerobic metabolism, which may lead to injuriesody mass index and waist circumference.
Figure 2 Comparison of VO2max (% predicted) stratified by level of physical activity in each group analysed.
Table 3 Correlations between VO2max and age, percentage
of body fat and waist circumference
VO2max (% pred) r p
Age (years) −0.401 0.044*
%F −0.429 0.011*
WC (cm) −0.382 0.025*
VO2max, maximum oxygen consumption; r, Pearson’s correlation coefficient.
Significance was accepted at p < 0.05.
*Analysis of Pearson’s correlation test and Analysis of Covariance (ANCOVA)
was also performed to compare VO2max and age, percentage of body fat and
waist circumference, among groups.
de Borba et al. Multidisciplinary Respiratory Medicine 2014, 9:34 Page 5 of 8
http://www.mrmjournal.com/content/9/1/34on the inside walls of blood vessels, making them more
rigid [44]. In our study, there was no difference in RQ
among groups, although it was slightly higher in ac-
tive smokers.
Unverdorben et al. [45] observed higher HR and rest-
ing SAP in active smokers than in non-smokers. This
fact can be explained by the action of nicotine, which ac-
tivates the sympathetic nervous system, leading to the
release of epinephrine and norepinephrine. The increase
in HR may cause heart diseases, which are associated
with smoking [46,47]. However, the increase in resting
HR may be influenced by psychological stress before
performing the CPET. In this study, there were no sig-
nificant differences among groups in resting HR or rest-
ing SAP, although the active smoker group had slightly
higher averages.
In our study, the maximum HR reached during the ex-
ertion test of the active smoker group was lower com-
pared with the others, as observed by Unverdorben et al.
[45]. Smokers who suffer from chronotropic incompe-
tence have a significantly increased risk of death and
coronary disease, and HR is an important predictor of
all-cause mortality [46]. A longitudinal study performed
in 2003 indicated that smoking was negatively associated
with the maximum HR obtained during CPET in men and
women between 13 and 36 years and that smokers reached
a maximum HR lower than in non-smokers [11]. Accord-
ing to Srivastava et al. [46] and Lauer et al. [47], smoking
also modifies the chronotropic response to exercise.
Similar to maximum HR, the maximum SAP reached
was slightly but not significantly lower in the active and
passive smoker groups. This finding indicates that smokers
have difficulty in maintaining appropriate cardiac output,
which can be explained by chronotropic incompetence.
Furthermore, the maximum DAP reached was higher
in the active and passive smoker groups compared with
the non-smokers, possibly due to a greater vasocon-
strictor tone.According to the IPAQ classifications, most individuals
were classified as sedentary or irregularly active (68.8%),
with a smaller proportion of active and awfully active indi-
viduals (31.3%). No significant results were found when
comparing VO2max stratified by level of physical activity
between any of two groups (p = 0.063) (Figure 2).
In our study, we expected to find an association between
smoking and sedentarism because smoking is described as
more prevalent in sedentary individuals and because phys-
ical activities can be a protective factor against beginning
habits such as smoking [20]. The lack of association be-
tween smoking and sedentariness may have been related to
the low degree of nicotine dependence because seven out
of 15 active smokers had a low or awfully low degree of
nicotine dependence. The IPAQ instrument used to iden-
tify the level of physical activity takes into consideration
several types of activities, including occupational and trans-
portation activities, which represent a large proportion of
the total activities that inhabitants of developing countries
engage in [48]. This description could explain the number
of active/awfully active individuals in this study.
As seen in Table 3, in the whole sample, VO2max was
correlated with age, %F and WC respectively. According
to Lee et al. [49], cardiorespiratory capacity depends on
modifiable factors (e.g., physical activity, smoking, obes-
ity and health conditions) and non-modifiable factors
(e.g., age, gender and genotype). After a person’s maximum
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and 30 years, a decline associated with age begins, espe-
cially if there are body weight gain and reduction of phys-
ical activity [50]. This study confirmed that greater age
and %F were associated with lower VO2max. Although
there was an association among age, %F and WC, these
variables did not affect the outcome of VO2max in the
groups. Furthermore, no significant differences were ob-
served between the level of physical activities and VO2max,
even though VO2max was lower in sedentary individuals
than in active ones. These findings support previous stud-
ies [51,52]. Cheng et al. [51] reported that smokers and
sedentary individuals had the worst results during the
Maximum Exertion Test and spirometry.
It is important to highlight the methodological limita-
tions of this study. A cross-sectional study is fast and
less expensive than other studies, but it is limited by its
brief time frame. For this reason, it was not possible to
evaluate the temporal relationships between causes and
effects. Regarding the determination of tobacco intake of
the subjects in this study it was not possible to quantify
the level of urinary cotinine, and therefore we used the
Fagerström Test for Nicotine Dependence, which is a
validated tool to quantify tobacco load [53,54]. The use
of questionnaires also limits the strength of our data be-
cause questions might not be answered completely due
to a lack of understanding or recall by the respon-
dents caused by their low education level or inability
to remember some aspects of the evaluation or even
because they unconsciously overestimated or underes-
timated their activities.
Recall bias related to active and passive smoking must
also be considered. The ability to determine one’s expos-
ure to tobacco smoke is potentially subject to informa-
tion bias, which may limit the interpretation of the
results. However, we classified passive smokers accord-
ing to the participants’ self-reports, as in other studies
[20,21]. In addition to costing less than other methods,
questionnaires to verify passive smoking are valid instru-
ments for projecting the level of cigarette smoke expos-
ure [36,55,56].
In our study the significant difference between passive
smokers and non-smokers could be explained by many
factors like the amounts of chemical substances coming
from environmental smoke that depend on number of
smokers, level of cigarette consumption, types of ciga-
rettes smoked (with or without strainer, tar content or
nicotine content), proximity to the passive smoker, dur-
ation of exposure, size of the exposure space, character-
istics of the ventilation system, age of the person exposed,
frequency of air exchange in the closed environment,
and use of air purifiers [57,58,36]. These variables were
not measured in our study, which may have limited the
generalizability of our results.Conclusions
This study, which aimed to identify the effects of smok-
ing on the cardiorespiratory capacity of active and pas-
sive smokers, found significant difference between active
smokers and non-smokers. Nevertheless, we found no
difference between active and passive smokers. VO2max
was negatively correlated with age, %F and WC. In con-
trast, there was no significant correlation between the
level of physical activity and VO2max, although sedentary
people showed lower maximum oxygen consumption
than the more active ones. Because the literature on pas-
sive smokers is limited, more studies on the effects of
passive smoking on cardiopulmonary fitness are neces-
sary and justified.
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